Application
Western blot analysis of extracts from Jurkat cells, using BORG4 Antibody. The lane on the right is treated with the synthesized peptide.| Product Name | BORG4 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to BORG4Probably involved in the organization of the actin cytoskeleton. May act downstream of CDC42 to induce actin filament assembly leading to cell shape changes. Induces pseudopodia formation, when overexpressed in fibroblasts. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human BORG4. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ELISAWB |
| ELISA: 1:20000Optimal dilutions should be determined experimentally by the end user.: |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | BORG4 Cdc42 effector protein4 binder of Rho GTPases 4 CDC42 effector protein (Rho GTPase binding) 4 CEP4 Cdc42 effector protein 4 binder of Rho GTPases4 |
|---|---|
| Target | BORG4 |
| Molecular Weight(MW) | 37 kDa (note) |
| Tissue Specificity | BORG4 Antibody detects endogenous levels of total BORG4 protein. |
Application
Western blot analysis of extracts from Jurkat cells, using BORG4 Antibody. The lane on the right is treated with the synthesized peptide.| Application Notes | ELISA: 1:20000Optimal dilutions should be determined experimentally by the end user.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20 degrees Celcius. Product is stable for at least 1 year. |
| Storage Buffer | Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
